Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Allergic Reactions

Allergic Reactions

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[The clinical value of multi-target stool fecal immunochemical test-DNA in early screening and diagnosis for colorectal cancer].

Zhonghua yi xue za zhi·2022

Same author

[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2018

Same author

Optimization of the Hewlett-Packard particle-beam liquid chromatography-mass spectrometry interface by statistical experimental design.

Journal of the American Society for Mass Spectrometry·2013

Same author

Optimization of the atmospheric pressure chemical ionization liquid chromatography mass spectrometry interface.

Journal of the American Society for Mass Spectrometry·2013

Same author

Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.

Cell death & disease·2013

Same author

A common environmental pollutant, 4-nonylphenol, promotes allergic lung inflammation in a murine model of asthma.

Allergy·2013

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Molecular modulation of allergic responses

¹Johns Hopkins Asthma and Allergy Center, Department of Medicine and Graduate Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

The Journal of Allergy and Clinical Immunology

|December 16, 1998

Summary

Allergic diseases involve complex molecular interactions and eosinophilic inflammation. New research suggests gene therapy and DNA immunization may offer novel ways to modulate these responses, paving the way for better treatments.

More Related Videos

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Related Experiment Videos

Last Updated: Jul 14, 2026

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Area of Science:

Immunology
Molecular Biology
Genetics

Background:

Allergic diseases are characterized by elevated serum IgE and TH2 cytokine-driven eosinophilic inflammation.
These factors present potential targets for immunomodulatory therapies.
Understanding the atopy network is crucial for developing effective treatments.

Purpose of the Study:

To explore novel prophylactic or therapeutic strategies for allergic diseases.
To investigate the potential of modulating antigen-induced allergic responses.
To deepen the understanding of molecular mechanisms in atopy.

Main Methods:

Mucosal transfer of TH1-cytokine genes in rodents.
Immunization with plasmid DNAs encoding sensitizing antigens in rodents.
Mapping regulatory pathways within the atopy network.

Main Results:

Evidence suggests antigen-induced allergic responses can be modulated by TH1-cytokine gene transfer.
Plasmid DNA immunization shows promise in modulating allergic responses.
Research is advancing the understanding of atopy regulatory pathways.

Conclusions:

Modulating TH1-cytokine genes and using DNA immunization are promising approaches for allergic disease treatment.
Further research into the atopy network will enhance the design of targeted therapies.
Innovative strategies offer new hope for managing allergic conditions.